308 related articles for article (PubMed ID: 28633901)
1. Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review.
Hase I; Morimoto K; Sakagami T; Ishii Y; van Ingen J
Diagn Microbiol Infect Dis; 2017 Aug; 88(4):308-315. PubMed ID: 28633901
[TBL] [Abstract][Full Text] [Related]
2. Disseminated Mycobacterium gordonae and Mycobacterium mantenii infection with elevated anti-IFN-γ neutralizing autoantibodies.
Hase I; Morimoto K; Sakagami T; Kazumi Y; Ishii Y; van Ingen J
J Infect Chemother; 2015 Jun; 21(6):468-72. PubMed ID: 25735882
[TBL] [Abstract][Full Text] [Related]
3. Pathogenicity of Mycolicibacterium phlei, a non-pathogenic nontuberculous mycobacterium in an immunocompetent host carrying anti-interferon gamma autoantibodies: a case report.
Tanaka S; Hoshino Y; Sakagami T; Fukano H; Matsui Y; Hiranuma O
BMC Infect Dis; 2019 May; 19(1):454. PubMed ID: 31117976
[TBL] [Abstract][Full Text] [Related]
4. Interferon-γ Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection.
Valour F; Perpoint T; Sénéchal A; Kong XF; Bustamante J; Ferry T; Chidiac C; Ader F;
Emerg Infect Dis; 2016 Jun; 22(6):1124-1126. PubMed ID: 27192204
[No Abstract] [Full Text] [Related]
5. Levels of anti-cytokine antibodies may be elevated in patients with pulmonary disease associated with non-tuberculous mycobacteria.
Kim K; Waterer G; Thomson R; Yang IA; Nashi N; Tan DB; Price P
Cytokine; 2014 Apr; 66(2):160-3. PubMed ID: 24508556
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease.
Aoki A; Sakagami T; Yoshizawa K; Shima K; Toyama M; Tanabe Y; Moro H; Aoki N; Watanabe S; Koya T; Hasegawa T; Morimoto K; Kurashima A; Hoshino Y; Trapnell BC; Kikuchi T
Clin Infect Dis; 2018 Apr; 66(8):1239-1245. PubMed ID: 29126235
[TBL] [Abstract][Full Text] [Related]
7. Functional neutralization of anti-IFN-γ autoantibody in patients with nontuberculous mycobacteria infection.
Krisnawati DI; Liu YC; Lee YJ; Wang YT; Chen CL; Tseng PC; Lin CF
Sci Rep; 2019 Apr; 9(1):5682. PubMed ID: 30952894
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-γ autoantibodies and disseminated nontuberculous mycobacterial infections.
Chi CY; Lin CH; Ho MW; Ding JY; Huang WC; Shih HP; Yeh CF; Fung CP; Sun HY; Huang CT; Wu TS; Chang CY; Liu YM; Feng JY; Wu WK; Wang LS; Tsai CH; Ho CM; Lin HS; Chen HJ; Lin PC; Liao WC; Chen WT; Lo CC; Wang SY; Kuo CY; Lee CH; Ku CL
Medicine (Baltimore); 2016 Jun; 95(25):e3927. PubMed ID: 27336882
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection.
Phoompoung P; Ankasekwinai N; Pithukpakorn M; Foongladda S; Umrod P; Suktitipat B; Mahasirimongkol S; Kiertiburanakul S; Suputtamongkol Y
PLoS One; 2017; 12(4):e0176342. PubMed ID: 28437431
[TBL] [Abstract][Full Text] [Related]
10. Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-γ autoantibodies in patients with disseminated nontuberculous mycobacterial infection.
Wu UI; Chuang YC; Sheng WH; Sun HY; Jhong YT; Wang JY; Chang SC; Wang JT; Chen YC
Clin Microbiol Infect; 2018 Feb; 24(2):159-165. PubMed ID: 28694201
[TBL] [Abstract][Full Text] [Related]
11. Repurposing QuantiFERON for Detection of Neutralizing Interferon-γ Autoantibodies in Patients With Nontuberculous Mycobacterial Infections.
Suárez I; Lehmann C; Gruell H; Graeb J; Kochanek M; Fätkenheuer G; Plum G; van Wengen A; van de Vosse E; Hartmann P; Hanitsch LG; Rybniker J
Clin Infect Dis; 2017 Aug; 65(3):518-521. PubMed ID: 28430999
[TBL] [Abstract][Full Text] [Related]
12. Disseminated Mycobacterium avium complex infection mimicking malignancy in a patient with anti-IFN-γ autoantibodies: a case report.
Yeh YK; Ding JY; Ku CL; Chen WC
BMC Infect Dis; 2019 Oct; 19(1):909. PubMed ID: 31664931
[TBL] [Abstract][Full Text] [Related]
13. Distinct Lymphocyte Immunophenotyping and Quantitative Anti-Interferon Gamma Autoantibodies in Taiwanese HIV-Negative Patients with Non-Tuberculous Mycobacterial Infections.
Lee WI; Fang YF; Huang JL; You HL; Hsieh MY; Huang WT; Liang CJ; Kang CC; Wu TS
J Clin Immunol; 2023 May; 43(4):717-727. PubMed ID: 36624329
[TBL] [Abstract][Full Text] [Related]
14. Disseminated Mycolicibacter arupensis and Mycobacterium avium co-infection in a patient with anti-interferon-γ neutralizing autoantibody-associated immunodeficiency syndrome.
Hirayama K; Kanda N; Suzuki T; Sasaki K; Kimura Y; Takahashi K; Matsumura M; Hatakeyama S
J Infect Chemother; 2022 Sep; 28(9):1336-1339. PubMed ID: 35691862
[TBL] [Abstract][Full Text] [Related]
15. Chronic Mycobacterium avium skin and soft tissue infection complicated with scalp osteomyelitis possibly secondary to anti-interferon-γ autoantibody formation.
Xu X; Lao X; Zhang C; Cao C; Ding H; Pang Y; Ning Q; Zou J; Zang N; Hu D; Chen M
BMC Infect Dis; 2019 Feb; 19(1):203. PubMed ID: 30819109
[TBL] [Abstract][Full Text] [Related]
16. Disseminated nontuberculous mycobacterial infection in a patient with idiopathic CD4 lymphocytopenia and IFN-γ neutralizing antibodies: a case report.
Goto R; Shiota S; Kaimori R; Horinouchi N; Utsunomiya Nishimizu R; Yamamoto K; Miyazaki E
BMC Infect Dis; 2023 Jan; 23(1):58. PubMed ID: 36717786
[TBL] [Abstract][Full Text] [Related]
17. Disseminated Nontuberculous Mycobacterial Infection in a Patient with Anti-IFN-γ Autoantibodies.
Tanimizu M; Mizuno K; Hashimoto M
Acta Med Okayama; 2017 Dec; 71(6):547-552. PubMed ID: 29276230
[TBL] [Abstract][Full Text] [Related]
18. Non-tuberculous mycobacterial infection and reactive dermatosis associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibodies: A case report.
Liang XN; Bin YF; Lai GT; Li YH; Zhang JQ; Zhong XN; Bai J; Li MH; Deng JM; He ZY
Medicine (Baltimore); 2020 Sep; 99(36):e21738. PubMed ID: 32899003
[TBL] [Abstract][Full Text] [Related]
19. NK Cell-Derived IFN-γ Protects against Nontuberculous Mycobacterial Lung Infection.
Lai HC; Chang CJ; Lin CS; Wu TR; Hsu YJ; Wu TS; Lu JJ; Martel J; Ojcius DM; Ku CL; Young JD; Lu CC
J Immunol; 2018 Sep; 201(5):1478-1490. PubMed ID: 30061197
[TBL] [Abstract][Full Text] [Related]
20. Juvenile-Onset Immunodeficiency Secondary to Anti-Interferon-Gamma Autoantibodies.
Liew WK; Thoon KC; Chong CY; Tan NWH; Cheng DT; Chan BSW; Ng MSY; Das L; Arkachaisri T; Huang CH; Kuan JL; Chai LYA; Koh MJA
J Clin Immunol; 2019 Jul; 39(5):512-518. PubMed ID: 31177358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
